(Health-NewsWire.Net, October 13, 2015 ) Portland, OR --
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Factor Assays testing closer to the patient, creating additional opportunities and challenges for suppliers. This report presents a detailed analysis of the Factor Assays testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.
The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Enquire about this report @ http://www.bigmarketresearch.com/report-enquiry/330942
Table of Contents:
I. Introduction
II. Worldwide Market and Technology Overview
A. Introduction B. Factor Assays: Clinical Significance and Current Laboratory Procedures C. Instrumentation Review D. Major in Vitro Diagnostic Technologies and Their Potential Applications III. France: Test Volume Forecasts by Market Segment IV. Germany: Test Volume Forecasts by Market Segment V. Italy: Test Volume Forecasts by Market Segment VI. Japan: Test Volume Forecasts by Market Segment VII. Spain: Test Volume Forecasts by Market Segment VIII. UK: Test Volume Forecasts by Market Segment IX. USA: Test Volume Forecasts by Market Segment X. Design Criteria For Decentralized Testing Products XI. Alternative Market Penetration Strategies
A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets 1. MARKETING APPROACHES 2. PRODUCT COMPLEXITY 3. CUSTOMER PREFERENCE 4. ESTABLISHED SUPPLIERS 5. EMERGING SUPPLIERS 6. MAJOR TYPES OF DISTRIBUTORS 7. MARKET SEGMENTATION
XII. Potential Market Entry Barriers and Risks
A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges
XIII. Competitive Assessments
Abbott ADI/American Diagnostica Alere/Biosite/Inverness Axis-Shield Beckman Coulter Becton Dickinson Bio/Data Corporation Chrono-Log Corgenix Medical Diagnostica Stago/Trinity Biotech Helena Laboratories HYPEN BioMed Instrumentation Laboratory ITC Roche Siemens Sienco Sysmex Thermo Fischer ZyCare/Alere
Contact Details:
James Jordan 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States Email: help@bigmarketresearch.com Web: http://www.bigmarketresearch.com
Big Market Research
James Jordan
+ 1-503-894-6022
james@bigmarketresearch.com
Source: EmailWire.Com
|